Gilead Average Assets vs Free Cash Flow Analysis

GILD Stock  USD 73.01  0.60  0.83%   
Trend analysis of Gilead Sciences balance sheet accounts such as Other Current Liabilities of 11.8 B or Total Current Liabilities of 11.8 B provides information on Gilead Sciences' total assets, liabilities, and equity, which is the actual value of Gilead Sciences to its prevalent stockholders. By breaking down trends over time using Gilead Sciences balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gilead Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.

About Gilead Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Gilead Sciences at a specified time, usually calculated after every quarter, six months, or one year. Gilead Sciences Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Gilead Sciences and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Gilead currently owns. An asset can also be divided into two categories, current and non-current.

Gilead Sciences Balance Sheet Chart

Gilead Sciences Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Gilead Sciences uses and utilizes its capital. It also shows what exactly a company owns and owes.
At present, Gilead Sciences' Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 11.8 B, whereas Cash is forecasted to decline to about 3.8 B.

Total Assets

Total assets refers to the total amount of Gilead Sciences assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Gilead Sciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Gilead Sciences balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Gilead Sciences are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most indicators from Gilead Sciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Gilead Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gilead Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.At present, Gilead Sciences' Tax Provision is projected to decrease significantly based on the last few years of reporting. The current year's Enterprise Value Multiple is expected to grow to 10.77, whereas Issuance Of Capital Stock is forecasted to decline to about 295.9 M.
 2021 2022 2023 2024 (projected)
Total Revenue27.3B27.3B27.1B28.5B
Interest Expense1.0B935M944M534.5M

Gilead Sciences fundamental ratios Correlations

0.850.90.980.950.910.70.93-0.050.40.830.260.520.180.98-0.12-0.270.990.610.620.730.80.470.540.560.53
0.850.720.780.710.820.940.68-0.20.180.750.350.41-0.070.890.07-0.230.880.450.680.370.720.530.380.530.49
0.90.720.930.90.810.640.87-0.10.20.750.120.450.190.85-0.2-0.530.880.530.420.650.780.360.570.470.32
0.980.780.930.960.90.660.910.00.320.850.250.440.250.93-0.19-0.310.960.540.590.730.820.390.620.550.45
0.950.710.90.960.880.540.950.030.440.780.220.490.340.87-0.18-0.360.90.590.520.740.790.410.60.460.37
0.910.820.810.90.880.750.77-0.250.180.950.470.170.050.87-0.07-0.40.890.260.680.570.960.230.730.620.35
0.70.940.640.660.540.750.48-0.27-0.170.750.370.15-0.180.76-0.01-0.240.750.190.620.210.710.350.440.540.41
0.930.680.870.910.950.770.48-0.030.550.640.070.680.190.88-0.27-0.280.90.760.440.770.650.540.370.40.47
-0.05-0.2-0.10.00.03-0.25-0.27-0.030.23-0.22-0.440.190.82-0.110.210.47-0.090.23-0.310.27-0.31-0.110.05-0.260.06
0.40.180.20.320.440.18-0.170.550.23-0.02-0.080.740.290.380.210.110.370.760.160.480.020.51-0.19-0.030.28
0.830.750.750.850.780.950.750.64-0.22-0.020.53-0.040.070.81-0.11-0.330.830.080.680.550.930.070.80.710.39
0.260.350.120.250.220.470.370.07-0.44-0.080.53-0.31-0.090.260.12-0.130.26-0.290.82-0.120.470.210.320.420.03
0.520.410.450.440.490.170.150.680.190.74-0.04-0.310.140.53-0.040.060.510.990.120.44-0.010.8-0.32-0.050.39
0.18-0.070.190.250.340.05-0.180.190.820.290.07-0.090.140.060.20.10.10.2-0.070.350.02-0.060.35-0.090.0
0.980.890.850.930.870.870.760.88-0.110.380.810.260.530.06-0.06-0.21.00.610.640.690.750.50.450.590.61
-0.120.07-0.2-0.19-0.18-0.07-0.01-0.270.210.21-0.110.12-0.040.2-0.060.08-0.09-0.05-0.03-0.12-0.04-0.080.020.02-0.05
-0.27-0.23-0.53-0.31-0.36-0.4-0.24-0.280.470.11-0.33-0.130.060.1-0.20.08-0.230.05-0.11-0.04-0.520.08-0.45-0.030.35
0.990.880.880.960.90.890.750.9-0.090.370.830.260.510.11.0-0.09-0.230.60.640.710.770.490.490.580.58
0.610.450.530.540.590.260.190.760.230.760.08-0.290.990.20.61-0.050.050.60.150.580.080.75-0.190.020.44
0.620.680.420.590.520.680.620.44-0.310.160.680.820.12-0.070.64-0.03-0.110.640.150.170.60.520.310.40.21
0.730.370.650.730.740.570.210.770.270.480.55-0.120.440.350.69-0.12-0.040.710.580.170.470.120.440.330.47
0.80.720.780.820.790.960.710.65-0.310.020.930.47-0.010.020.75-0.04-0.520.770.080.60.470.060.790.630.17
0.470.530.360.390.410.230.350.54-0.110.510.070.210.8-0.060.5-0.080.080.490.750.520.120.06-0.350.060.32
0.540.380.570.620.60.730.440.370.05-0.190.80.32-0.320.350.450.02-0.450.49-0.190.310.440.79-0.350.430.07
0.560.530.470.550.460.620.540.4-0.26-0.030.710.42-0.05-0.090.590.02-0.030.580.020.40.330.630.060.430.65
0.530.490.320.450.370.350.410.470.060.280.390.030.390.00.61-0.050.350.580.440.210.470.170.320.070.65
Click cells to compare fundamentals

Gilead Sciences Account Relationship Matchups

Gilead Sciences fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets61.6B68.4B68.0B63.2B62.1B65.2B
Short Long Term Debt Total24.6B31.4B26.7B25.2B25.0B26.2B
Other Current Liab6.5B7.8B9.4B8.1B11.3B11.8B
Total Current Liabilities9.8B11.4B11.6B11.2B11.3B11.8B
Total Stockholder Equity22.7B18.2B21.1B21.2B22.7B23.9B
Property Plant And Equipment Net4.5B5.0B5.1B5.5B5.3B5.6B
Net Debt13.0B25.4B21.4B19.8B18.9B19.8B
Retained Earnings19.4B14.4B16.3B15.7B16.3B17.1B
Accounts Payable713M844M705M905M550M518.2M
Cash11.6B6.0B5.3B5.4B6.1B3.8B
Non Current Assets Total30.1B52.6B52.9B47.9B45.7B48.0B
Non Currrent Assets Other7.7B6.4B6.0B4.0B5.6B5.9B
Cash And Short Term Investments25.8B7.9B7.8B7.6B8.4B7.5B
Common Stock Shares Outstanding1.3B1.3B1.3B1.3B1.3B1.5B
Liabilities And Stockholders Equity61.6B68.4B68.0B63.2B62.1B65.2B
Non Current Liabilities Total29.2B38.8B35.3B30.7B28.1B29.5B
Other Current Assets1.4B2.0B2.1B1.8B2.4B1.3B
Other Stockholder Equity3.2B3.9B4.7B5.5B(16.3B)(15.5B)
Total Liab39.0B50.2B46.9B42.0B39.4B41.3B
Total Current Assets31.5B15.8B15.1B15.2B16.5B10.8B
Short Term Debt2.5B2.8B1.5B2.3B1.8B1.9B
Net Receivables3.6B4.9B4.5B4.8B4.7B2.4B
Property Plant And Equipment Gross4.5B5.0B7.0B7.7B7.8B8.2B
Accumulated Other Comprehensive Income85M(60M)83M2M28M37.6M
Short Term Investments12.7B1.4B1.2B973M1.2B1.1B
Inventory2.1B3.0B2.7B2.8B3.4B3.5B
Other Liab6.5B9.5B35.3B7.3B8.4B8.8B
Other Assets3.1B4.8B6.0B1M1.2M1.1M
Long Term Debt22.1B28.6B25.2B23.0B23.2B12.2B
Property Plant Equipment4.5B5.0B5.1B5.5B6.3B6.6B
Net Tangible Assets4.6B(23.0B)(20.7B)(16.0B)(14.4B)(13.7B)
Noncontrolling Interest In Consolidated Entity125M19M(5M)(31M)(27.9M)(26.5M)
Retained Earnings Total Equity19.4B14.4B16.3B15.7B18.0B12.7B
Long Term Debt Total22.1B28.6B25.2B23.0B26.4B19.7B
Capital Surpluse3.1B3.9B4.7B5.6B5.0B2.7B

Gilead Sciences Investors Sentiment

The influence of Gilead Sciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Gilead. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Gilead Sciences' public news can be used to forecast risks associated with an investment in Gilead. The trend in average sentiment can be used to explain how an investor holding Gilead can time the market purely based on public headlines and social activities around Gilead Sciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Gilead Sciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Gilead Sciences' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Gilead Sciences' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Gilead Sciences.

Gilead Sciences Implied Volatility

    
  24.93  
Gilead Sciences' implied volatility exposes the market's sentiment of Gilead Sciences stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Gilead Sciences' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Gilead Sciences stock will not fluctuate a lot when Gilead Sciences' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Gilead Sciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Gilead Sciences' short interest history, or implied volatility extrapolated from Gilead Sciences options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Gilead Sciences is a strong investment it is important to analyze Gilead Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Gilead Sciences' future performance. For an informed investment choice regarding Gilead Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gilead Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Complementary Tools for Gilead Stock analysis

When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Is Gilead Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gilead Sciences. If investors know Gilead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gilead Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.13)
Dividend Share
3
Earnings Share
4.5
Revenue Per Share
21.728
Quarterly Revenue Growth
(0.04)
The market value of Gilead Sciences is measured differently than its book value, which is the value of Gilead that is recorded on the company's balance sheet. Investors also form their own opinion of Gilead Sciences' value that differs from its market value or its book value, called intrinsic value, which is Gilead Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gilead Sciences' market value can be influenced by many factors that don't directly affect Gilead Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gilead Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Gilead Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gilead Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.